Howard's Business Report: Elliott Parks

(HawaiiNewsNow) - Hawaii Biotech Inc. will receive a $261,990 federal grant to support the research and development of a vaccine for Crimean- Congo Hemorrhagic Fever. The money is coming from a Small Business Innovation Research Grant administered by the U.S. Department of Health and Human Service's National Institute of Allergy and Infectious Diseases, Senator Daniel Inouye's office said Wednesday. Howard talks with Elliot Oarks, CEO of Hawaii Biotech Inc.

Copyright 2012 Hawaii News Now. All rights reserved